Cargando…
Mycophenolate mofetil‐induced peripheral neuropathy in the treatment of membranous glomerulonephropathy: A case report
Mycophenolate mofetil (MMF) as an immunosuppressive agent is widely used in the management of Membranous Glomerulonephropathy (MGN). In this report, we described a 66‐year‐old male MGN case treated with MMF and revealed acquired sensory‐motor axonal polyneuropathy, which is rare and has not been rep...
Autores principales: | Moghimi, Minoo, Nekoukar, Zahra, Gholami, Farhad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667295/ https://www.ncbi.nlm.nih.gov/pubmed/34938547 http://dx.doi.org/10.1002/ccr3.5161 |
Ejemplares similares
-
Mycophenolate mofetil: Cytopenia: case report
Publicado: (2021) -
Successful long-term treatment of paraneoplastic optic neuropathy with mycophenolate mofetil, prednisone, and plasmapheresis
por: Durrani, Alia, et al.
Publicado: (2017) -
Mycophenolate-mofetil/mycophenolic-acid: COVID-19: 4 case reports
Publicado: (2021) -
Mycophenolate-mofetil/valganciclovir: Neutropenia: case report
Publicado: (2022) -
Mycophenolate mofetil–induced hyperlipidemia with cutaneous manifestations
por: Yim, Rebecca M., et al.
Publicado: (2023)